Home Companies

Companies

Latest

Genome Editing

Sanofi, Scribe Launch Up-to-$1B CRISPR-Based Cancer NK Cell Therapy Collaboration

GEN 40

StockWatch: After Bluebird’s Second Approval, Investors Are Looking for More

Companies

SpIntellx Powers Precision Pathology with Spatial AI

Illumina

StockWatch: Illumina Bounces Back After FTC Win, EU Loss

Ant

Companies

Longevity in Ants Linked to Altered Insulin Signaling

Illumina

Judge Sides with Illumina, Rejecting FTC Challenge to Grail Deal

Protein Therapeutics

Engineerable Biology: Generate Builds Pipeline, Expands Modalities

Cell Therapy

Pipeline Progress: Sangamo CEO Discusses Cell, Gene Therapies

3D illustration XY-chromosomes as a concept for human biology medical symbol gene therapy or microbiology genetics research

Gene Therapy

Novartis Confirms Deaths of Two Patients Treated with Gene Therapy Zolgensma

Coronavirus

StockWatch: Novavax Sinks with Revenue Forecast, Vaccine Demand

Autoimmune Disease Drugs

Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio

Abstract luminous DNA molecule. Genetic and gene manipulation concept. Cut of replacing part of a DNA molecule. Medicine. Innovative in science. Medical science and biotechnology.

Companies

Junk DNA’s Potential Role in Cancer

Financing

StockWatch: Layoffs Fail to Lift Novartis

Genome Editing

Beyond CRISPR: Precision Bio Lands Up-to-$1.5B Editing Deal with Novartis

Novartis

Novartis Eliminating 8,000 Jobs in Global Restructuring

12 3...66 Page 1 of 66